NYSEAMERICAN : CCEL
Cryo-Cell International, Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 5.21 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 42.01M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 42.01M |
| Enterprise Value | 46.59M |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 9, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 8.06M |
| Shares Outstanding | 8.06M |
| Shares Change (YoY) | -0.18% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 39.35% |
| Owned by Institutions (%) | 6.89% |
| Float | 4.12M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 65.13 |
| PS Ratio | 1.35 |
| Forward PS | 1.46 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.03 |
| P/OCF Ratio | 8.54 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.50 |
| EV / EBITDA | 40.14 |
| EV / EBIT | 245.99 |
| EV / FCF | 10.02 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.86 |
| Quick Ratio | 0.72 |
| Debt / Equity | n/a |
| Debt / EBITDA | 5.42 |
| Debt / FCF | 1.90 |
| Interest Coverage | 0.10 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 0.19% |
| Return on Invested Capital (ROIC) | 0.41% |
| Return on Capital Employed (ROCE) | 0.40% |
| Weighted Average Cost of Capital (WACC) | 9.03% |
| Revenue Per Employee | $409,560 |
| Profits Per Employee | -$25,595 |
| Employee Count | 76 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 18.57 |
Taxes
| Measure | Value |
|---|
| Income Tax | 36,817 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.59 |
| 52-Week Price Change | +18.38% |
| 50-Day Moving Average | 4.31 |
| 200-Day Moving Average | 3.68 |
| Relative Strength Index (RSI) | 64.25 |
| Average Volume (20 Days) | 13,500 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 9,453 |
| Short Previous Month | 9,397 |
| Short % of Shares Out | 0.12% |
| Short % of Float | 0.23% |
| Short Ratio (days to cover) | 0.53 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 31.13M |
| Gross Profit | 20.09M |
| Operating Income | 189,419 |
| Pretax Income | -1.91M |
| Net Income | -1.95M |
| EBITDA | 1.16M |
| EBIT | 189,419 |
| Loss Per Share | -$0.24 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 4.23M |
| Total Debt | 8.82M |
| Net Cash | -4.59M |
| Net Cash Per Share | -$0.57 |
| Equity (Book Value) | -16.39M |
| Book Value Per Share | -2.03 |
| Working Capital | -2.16M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 4.92M |
| Capital Expenditures | -268,871 |
| Depreciation & Amortization | 971,385 |
| Net Borrowing | -3.37M |
| Free Cash Flow | 4.65M |
| FCF Per Share | $0.58 |
Margins
| Measure | Value |
|---|
| Gross Margin | 64.53% |
| Operating Margin | 0.61% |
| Pretax Margin | -6.13% |
| Profit Margin | -6.25% |
| EBITDA Margin | 3.73% |
| EBIT Margin | 0.61% |
| FCF Margin | 14.94% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.18% |
| Shareholder Yield | 0.18% |
| Earnings Yield | -4.64% |
| FCF Yield | 11.07% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -0.12 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |